EIF4B and breast neoplasm: To assess eIF4A1 helicase activity in breast tumors, tissue microarrays (TMAs) derived from 3903 patients were scored for eIF4E, eIF4A1, eIF4B and PDCD4 (summarized in Table 1 and Supplementary Table 1).